Microbiome Influence in the Pathogenesis of Prion and Alzheimer's Diseases

Misfolded and abnormal beta-sheets forms of wild-type proteins, such as cellular prion protein (PrPC) and amyloid beta (A beta), are believed to be the vectors of neurodegenerative diseases, prion and Alzheimer's disease (AD), respectively. Increasing evidence highlights the prion-like seeding of protein aggregates as a mechanism for pathological spread in AD, tauopathy, as well as in other neurodegenerative diseases, such as Parkinson's. Mutations in both PrPC and A beta precursor protein (APP), have been associated with the pathogenesis of these fatal disorders with clear evidence for their pathogenic significance. In addition, a critical role for the gut microbiota is emerging; indeed, as a consequence of gut-brain axis alterations, the gut microbiota has been involved in the regulation of A beta production in AD and, through the microglial inflammation, in the amyloid fibril formation, in prion diseases. Here, we aim to review the role of microbiome (the other human genome) alterations in AD and prion disease pathogenesis.